NCT05294536View on ClinicalTrials.gov

A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 22, 2020

Primary Completion Date

July 20, 2020

Study Completion Date

November 27, 2020

Conditions

Type 2 Diabetes

Interventions

DRUG

Liraglutide injection,RD12014

single dose, s.c. injection

DRUG

Liraglutide injection,Victoza

single dose, s.c. injection

Trial Locations (1)

200031

Shanghai Xuhui Central Hospital, Shanghai

All Listed Sponsors

lead

Sunshine Lake Pharma Co., Ltd.

INDUSTRY

NCT05294536 - A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter